Below are the most recent publications written about "Respiratory Function Tests" by people in Profiles.
-
Asghar A, Fonseca-Paricio M, Ravikumar N, Hammer MM, Forth V, Wagh A, Hogarth DK, Shafiq M. Sequential Bilateral Bronchoscopic Lung Volume Reduction for Residual Hyperinflation Following Successful Index Procedure in Pulmonary Emphysema: A Multicenter Study. J Bronchology Interv Pulmonol. 2026 Apr 01; 33(2).
-
Moore PE, Hayden LP, Villafranco NM, Toprak D, Rice JL, Rhein LM, Popova AP, McKinney RL, Manimtim WM, Levin JC, Lai KV, Gage SC, Bansal M, Baker CD, Austin ED, Agarwal A, McGrath-Morrow SA, Collaco JM. Outpatient clinical care for bronchopulmonary dysplasia: A survey of the BPD collaborative. Pediatr Pulmonol. 2025 Jan; 60(1):e27296.
-
Doumat G, Mehta GD, Espinola JA, Gallegos C, Zhu Z, Mansbach JM, Hasegawa K, Camargo CA. Race-Neutral Equations and Pulmonary Function Test Interpretation in Two Pediatric Cohorts. J Pediatr. 2024 10; 273:114124.
-
Mehta GD, Arroyo AC, Zhu Z, Espinola JA, Mansbach JM, Hasegawa K, Camargo CA. Association between severe bronchiolitis in infancy and age 6-year lung function. Respir Med. 2023 11; 218:107401.
-
McKleroy W, Shing T, Anderson WH, Arjomandi M, Awan HA, Barjaktarevic I, Barr RG, Bleecker ER, Boscardin J, Bowler RP, Buhr RG, Criner GJ, Comellas AP, Curtis JL, Dransfield M, Doerschuk CM, Dolezal BA, Drummond MB, Han MK, Hansel NN, Helton K, Hoffman EA, Kaner RJ, Kanner RE, Krishnan JA, Lazarus SC, Martinez FJ, Ohar J, Ortega VE, Paine R, Peters SP, Reinhardt JM, Rennard S, Smith BM, Tashkin DP, Couper D, Cooper CB, Woodruff PG. Longitudinal Follow-Up of Participants With Tobacco Exposure and Preserved Spirometry. JAMA. 2023 08 01; 330(5):442-453.
-
Wilson KC. Role of Race in the Interpretation of Pulmonary Function Tests: The American Thoracic Society's Efforts to Mitigate Bias in Its Clinical Guidance. Am J Respir Crit Care Med. 2023 04 15; 207(8):961-962.
-
Presti TP, Johnson DC. Improving pulmonary function test interpretation. Eur Respir J. 2023 01; 61(1).
-
Ghosh AJ, Hobbs BD, Moll M, Saferali A, Boueiz A, Yun JH, Sciurba F, Barwick L, Limper AH, Flaherty K, Criner G, Brown KK, Wise R, Martinez FJ, Lomas D, Castaldi PJ, Carey VJ, DeMeo DL, Cho MH, Silverman EK, Hersh CP. Alpha-1 Antitrypsin MZ Heterozygosity Is an Endotype of Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2022 02 01; 205(3):313-323.
-
O'Toole J, Woo H, Putcha N, Cooper CB, Woodruff P, Kanner RE, Paine R, Bowler RP, Comellas A, Hoth KF, Krishnan JA, Han M, Dransfield M, Iyer AS, Couper D, Peters SP, Criner G, Kim V, Barr RG, Martinez FJ, Hansel NN, Eakin MN. Comparative Impact of Depressive Symptoms and FEV1% on Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc. 2022 02; 19(2):171-178.
-
Marfil-S?nchez A, Seelbinder B, Ni Y, Varga J, Berta J, Hollosi V, Dome B, Megyesfalvi Z, Dulka E, Galffy G, Weiss GJ, Panagiotou G, Lohinai Z. Gut microbiome functionality might be associated with exercise tolerance and recurrence of resected early-stage lung cancer patients. PLoS One. 2021; 16(11):e0259898.